Sciele Pharma Inc. v. Mylan Pharmaceuticals Inc.
1:07-cv-00664
Overview
Parties
Defendant
Mylan Laboratories Inc. Operating Company
Represented By
1 Attorneys ListedMorris James LLP
500 Delaware Avenue, Suite 1500, P.O. Box 2306
Mylan Pharmaceuticals Inc. Operating Company
Represented By
1 Attorneys ListedMorris James LLP
500 Delaware Avenue, Suite 1500, P.O. Box 2306
Plaintiff
Sciele Pharma Cayman Ltd. Operating Company
Represented By
3 Attorneys ListedFish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Sciele Pharma Inc. Operating Company
Represented By
2 Attorneys ListedFish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 4,892,741 Asserted | Asserted Patent | View Official Patent → |
| π©πͺ Germany | DE 1987372075 | Germany Counterpart | View Official Patent → |
| π©πͺ Germany | DE 3720757 A1 | Germany Counterpart | View Official Patent → |
| π©πͺ Germany | DE 3720751 | Germany Counterpart | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US4892741
Press coated DHP tablets
|
Filed: 1988-06-08
Issued: 1990-01-09
|
Expired (Term Ended)
Expires: 2008-06-08
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
16
Dispositive
14
Granted
0
Denied
0
Pending / Review
15
Motions by Category
Key Dispositive Motions & Rulings